Cargando…
Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases
DNA vaccines are considered as a third-generation vaccination approach in which antigenic materials are encoded as DNA plasmids for direct in vivo production to elicit adaptive immunity. As compared to other platforms, DNA vaccination is considered to have a strong safety profile, as DNA plasmids ne...
Autores principales: | Xu, Ziyang, Patel, Ami, Tursi, Nicholas J., Zhu, Xizhou, Muthumani, Kar, Kulp, Daniel W., Weiner, David B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757735/ https://www.ncbi.nlm.nih.gov/pubmed/35047878 http://dx.doi.org/10.3389/fmedt.2020.571030 |
Ejemplares similares
-
Synthetic DNA delivery by electroporation promotes robust in vivo sulfation of broadly neutralizing anti-HIV immunoadhesin eCD4-Ig
por: Xu, Ziyang, et al.
Publicado: (2018) -
Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants
por: Flingai, Seleeke, et al.
Publicado: (2013) -
Harnessing artificial intelligence in radiology to augment population health
por: Sim, Jordan Z. T., et al.
Publicado: (2023) -
Synthetic DNA Delivery of an Engineered Arginase Enzyme Can Modulate Specific Immunity In Vivo
por: Khoshnejad, Makan, et al.
Publicado: (2020) -
Recent technologies in cardiac imaging
por: Counseller, Quinn, et al.
Publicado: (2023)